Senti Biosciences (SNTI) Total Liabilities (2021 - 2025)

Senti Biosciences has reported Total Liabilities for 5 years, with the latest figure at $45.6 million in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities fell 3.08% year-over-year to $45.6 million; the trailing twelve-month figure through Dec 2025 stood at $45.6 million (down 3.08% YoY), and the FY2025 full-year result was $45.6 million, down 3.08% from the prior year.
• Total Liabilities for Q4 2025 stood at $45.6 million, up from $44.6 million in the prior quarter.
• The five-year high for Total Liabilities was $53.5 million in Q4 2022, with the low at $349835.0 in Q1 2021.
• Average Total Liabilities over 5 years is $38.4 million, with a median of $45.3 million recorded in 2025.
• Year-over-year, Total Liabilities surged 3073.28% in 2022 and dropped 14.55% in 2024.
• Tracing SNTI's Total Liabilities over 5 years: stood at $36.3 million in 2021, then surged by 47.36% to $53.5 million in 2022, then slipped by 1.79% to $52.6 million in 2023, then declined by 10.43% to $47.1 million in 2024, then declined by 3.08% to $45.6 million in 2025.
• The last three Total Liabilities figures came in at $45.6 million (Q4 2025), $44.6 million (Q3 2025), and $43.9 million (Q2 2025), per Business Quant data.

Peer Comparison